Incidence, Risk Factors and Outcomes of Diaphragm Dysfunction After Lung Transplantation

University Health Network, Toronto15 enrolled

Overview

The study is designed to characterize the changes in diaphragm function after lung transplantation.

Diaphragm dysfunction (DD) is a well-known complication after lung transplantation. Patients with an injured and dysfunctional diaphragm have greater difficulty weaning from mechanical ventilation post-transplant - they become too weak to breathe. However, little is known about the pre-transplant predictive factors associated with diaphragm dysfunction . We have developed a new technique employing beside ultrasound to measure diaphragm thickness. This allows us to observe changes in diaphragm muscle structure and function. The goal of the study is to determine whether pre-transplant diaphragm thickness and function are associated with diaphragmatic dysfunction after lung transplantation. This will help us to confirm the best way to avoid diaphragm injury and to understanding the meaning of diaphragm ultrasound images.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Diaphragm Injury Lung Transplant; Complications, Mechanical Respiratory Failure Mechanical Ventilation Complication

Interventions

UltrasoundDIAGNOSTIC_TEST

Sonographic measurements (diaphragm, abdominal muscle, and quadriceps thickness) will be acquired when listed for lung transplantation. Sonographic measurements will be recorded on a daily basis for up to 1 week after transplantation (while the patient remains intubated).

Respiratory function measurementsDIAGNOSTIC_TEST

Maximal expiratory pressure (MEP) and maximal inspiratory pressure (MIP) will be acquired after listing for lung transplantation. After transplant, MIP will be recorded once patients are eligible for a trial of spontaneous breathing and weekly thereafter. MEP will also be recorded at ICU discharge.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adult patients greater than 18 years of age * Listed for lung transplantation Exclusion Criteria: * Known diagnosis of chronic neuromuscular disease * Relisting for transplantation * Bridging to lung transplantation with respiratory support

Locations (1)

Toronto General Hospital

Toronto, Canada

Outcomes

Primary Outcomes

Incidence of diaphragm dysfunction at the first spontaneous breathing trial and at ICU discharge after lung transplantation

Diaphragm ultrasound will be used to visualize diaphragm dysfunction (maximal thickening fraction \<20%)

Time frame: First spontaneous breathing trial, an average of 1 to 7 days

Secondary Outcomes

Pre-transplant diaphragm thickness and function compared to post-transplant diaphragm dysfunction

Diaphragm thickness and function documented on ultrasound will be assessed

Time frame: 1 day

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.